Position in NVS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$81,337
-$78 QoQ
Shares Held
519
-2.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,393
of 1,603 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Purpose Unlimited Inc. holds $21,432,780 across 11 Drug Manufacturers - General names. NVS ranks #9 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
100,180 | $12,873,129 | |
| 2 | AZN |
Astrazeneca PLC
|
15,503 | $2,939,678 | |
| 3 | LLY |
ELI LILLY & Co
|
1,253 | $1,502,884 | |
| 4 | AMGN |
Amgen Inc
|
3,970 | $1,437,616 | |
| 5 | JNJ |
Johnson & Johnson
|
4,753 | $1,207,118 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
7,683 | $970,669 | |
| 7 | ABBV |
AbbVie Inc.
|
754 | $189,736 | |
| 8 | NVO |
Novo Nordisk A S
|
3,739 | $179,247 |
All Filings in NVS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $81,337 | 519 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $81,415 | 533 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $81,894 | 594 | Shares | Sole | 2026-03-20 | |
| No filing history on record for this holder in this stock. | ||||||